Pneumonia severity index
Pneumonia Severity Index (PSI) is a clinical prediction rule that medical practitioners use to calculate the probability of morbidity and mortality among patients with community-acquired pneumonia. This index helps in the management of patients by identifying those who may require hospitalization or intensive care.
Overview[edit | edit source]
The Pneumonia Severity Index was developed by Fine MJ et al. in 1997. It uses a combination of patient's age, co-morbid illness, physical examination findings, and laboratory and radiographic findings to categorize patients into five risk classes. These classes predict the risk of short-term mortality and other adverse outcomes.
Calculation[edit | edit source]
The PSI score is calculated based on 20 variables. These variables include demographic factors, co-morbid illnesses, physical examination findings, and laboratory and radiographic findings. Each variable is assigned a point value, and the total score determines the patient's risk class.
Risk Classes[edit | edit source]
The PSI divides patients into five risk classes:
- Class I: Very low risk of mortality. Outpatient care is usually sufficient.
- Class II: Low risk of mortality. Outpatient care or observation is usually sufficient.
- Class III: Moderate risk of mortality. Short inpatient hospitalization or closely monitored outpatient care is recommended.
- Class IV: High risk of mortality. Inpatient hospitalization is recommended.
- Class V: Very high risk of mortality. Consideration for intensive care is recommended.
Limitations[edit | edit source]
While the PSI is a useful tool, it has some limitations. It may underestimate the severity of illness in younger patients with few comorbidities. It also does not consider the social factors that may affect a patient's ability to receive outpatient treatment.
See Also[edit | edit source]
Translate: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD